Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof

Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof

US Patent 9487587 · Granted Nov 8, 2016

Estimated economic value: $13,181,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific molecules comprising an HIV-1 envelope targeting arm2024
LAG-3-binding molecules and methods of use thereof2024
Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA2023
Methods for the treatment of disease using immunoglobulins having fc regions wit2023
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and u2023
PD-1-binding molecules and methods of use thereof2023
Bispecific molecules that are immunoreactive with immune effector cells that exp2022
Combination therapy for the treatment of cancer2021
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and met2021
Combination therapy for the treatment of cancer2021
LAG-3-binding molecules and methods of use thereof2021
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods o2021